Treatment of advanced breast cancer in women w/ natural or artificially induced postmenopausal status, who have previously been treated w/ antiestrogens. Also as 1st-line treatment in postmenopausal women w/ advanced breast cancer & pre-op therapy in postmenopausal women w/ localized hormone receptor +ve breast cancer to allow subsequent breast conserving surgery in women not originally considered candidate for this type of surgery, subsequent treatment after surgery should be in accordance w/ standard of care.
Dosage/Direction for Use
Adult & elderly 2.5 mg once daily. No dose adjustment is required for elderly patients.
Renal & severe hepatic impairment (Child-Pugh score C). Monitor overall bone health during treatment. May affect ability to drive or operate machinery.
Sign Out
